Related Experiment Video

Updated: Jan 25, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

6.6K

Inhaled Cisplatin for NSCLC: Facts and Results

Christoforos Kosmidis1, Konstantinos Sapalidis2, Paul Zarogoulidis3,4

  • 13rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, 57001 Thessaloniki, Greece. dr.ckosmidis@gmail.com.

International Journal of Molecular Sciences
|April 27, 2019
PubMed

Insights

Inhaled cisplatin offers a novel approach for non-small cell lung cancer (NSCLC) treatment, aiming for more efficient drug delivery. This review examines existing data on inhaled cisplatin administration for improved NSCLC patient outcomes.

Area of Science:

  • Oncology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Non-small cell lung cancer (NSCLC) diagnosis often occurs at advanced stages, despite advancements in diagnostic tools.
  • Emerging targeted therapies and immunotherapies are transforming NSCLC treatment paradigms.
  • Efficient and safe drug administration remains a critical challenge in managing NSCLC.

Purpose of the Study:

  • To review and analyze published data on the administration of inhaled cisplatin for non-small cell lung cancer.
  • To evaluate the potential of inhaled cisplatin as an improved drug delivery method for NSCLC.

Main Methods:

  • Systematic review of published literature on inhaled cisplatin in NSCLC.
  • Analysis of studies focusing on drug delivery, efficacy, and safety profiles.
  • Examination of pharmacokinetic and pharmacodynamic data where available.

Main Results:

  • Inhaled cisplatin presents a promising alternative for localized drug delivery to the lungs.
  • Published data suggests potential for reduced systemic toxicity compared to conventional cisplatin administration.
  • Further research is needed to optimize dosing, delivery devices, and patient selection for inhaled cisplatin therapy.

Conclusions:

  • Inhaled cisplatin administration is a viable strategy for improving NSCLC treatment efficiency and safety.
  • This delivery method warrants further investigation to establish its clinical utility and optimal application in NSCLC management.
  • Continued research into novel drug delivery systems is crucial for advancing cancer therapy.
Keywords:
NSCLCcisplatininhalationlung cancernebulizers

More Related Videos

Whole-Body Nanoparticle Aerosol Inhalation Exposures10:11

Whole-Body Nanoparticle Aerosol Inhalation Exposures

Published on: May 7, 2013

16.3K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.4K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
769
Pulmonary Ventilation: Inhalation01:24

Pulmonary Ventilation: Inhalation

Pulmonary ventilation is a vital process that ensures the exchange of oxygen and carbon dioxide in the lungs. It refers to the movement of air into and out of the lungs, enabling the body to obtain oxygen and remove waste carbon dioxide. In this article, we will explore the intricacies of pulmonary ventilation, including its underlying principles, mechanisms, and the interplay of pressures within the respiratory system.
Boyle's law becomes particularly pertinent when examining respiratory...
7.8K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Stereoisomerism02:52

Stereoisomerism

Isomerism in Complexes
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
14.0K
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K